Chemical Compound

2-[4-Fluoro-3-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-2-[1,2,4]- triazolo[1,5-a]- pyrazin-8-yl- acetamide1H NMR (500 MHz, DMSO-d6) ppm = 9.10 (s,1H), 9.02 (d, J = 4.5, 1H), 8.74 (s, 1H), 8.21 (d,J = 4.5, 1H), 7.79-7.75 (m, 1H), 7.74-7.69 (m,2H), 7.64 (dd, J = 9.4, 2.9, 1H), 7.56 (dd, J = 9.5,2.5, 1H), 7.45-7.40 (m, 1H), 7.31-7.27 (m, 1H),7.20 (d, J = 2.4, 1H), 5.89 (s, 1H), 3.81-3.74 (m,4H), 3.49-3.41 (m, 4H).

2-[4-Fluoro-3-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-2-[1,2,4]- triazolo[1,5-a]- pyrazin-8-yl- acetamide1H NMR (500 MHz, DMSO-d6) ppm = 9.10 (s,1H), 9.02 (d, J = 4.5, 1H), 8.74 (s, 1H), 8.21 (d,J = 4.5, 1H), 7.79-7.75 (m, 1H), 7.74-7.69 (m,2H), 7.64 (dd, J = 9.4, 2.9, 1H), 7.56 (dd, J = 9.5,2.5, 1H), 7.45-7.40 (m, 1H), 7.31-7.27 (m, 1H),7.20 (d, J = 2.4, 1H), 5.89 (s, 1H), 3.81-3.74 (m,4H), 3.49-3.41 (m, 4H). 结构式
Primary record

2-[4-Fluoro-3-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-2-[1,2,4]- triazolo[1,5-a]- pyrazin-8-yl- acetamide1H NMR (500 MHz, DMSO-d6) ppm = 9.10 (s,1H), 9.02 (d, J = 4.5, 1H), 8.74 (s, 1H), 8.21 (d,J = 4.5, 1H), 7.79-7.75 (m, 1H), 7.74-7.69 (m,2H), 7.64 (dd, J = 9.4, 2.9, 1H), 7.56 (dd, J = 9.5,2.5, 1H), 7.45-7.40 (m, 1H), 7.31-7.27 (m, 1H),7.20 (d, J = 2.4, 1H), 5.89 (s, 1H), 3.81-3.74 (m,4H), 3.49-3.41 (m, 4H).

库存
550 克
纯度
98.1 %

化合物标识与属性

PubChem CID
117711775
SMILES
C1COCCN1C2=CC3=C(C=C2)C(=NC=N3)C4=C(C=CC(=C4)C(C5=NC=CN6C5=NC=N6)C(=O)N)F
Canonical SMILES
NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccn2ncnc12

名称与同义词

  • CHEMBL5927502
  • SCHEMBL16256239
  • BDBM315855
  • US10172859, Example 280
  • 2-[4-Fluoro-3-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-2-[1,2,4]- triazolo[1,5-a]- pyrazin-8-yl- acetamide1H NMR (500 MHz, DMSO-d6) ppm = 9.10 (s,1H), 9.02 (d, J = 4.5, 1H), 8.74 (s, 1H), 8.21 (d,J = 4.5, 1H), 7.79-7.75 (m, 1H), 7.74-7.69 (m,2H), 7.64 (dd, J = 9.4, 2.9, 1H), 7.56 (dd, J = 9.5,2.5, 1H), 7.45-7.40 (m, 1H), 7.31-7.27 (m, 1H),7.20 (d, J = 2.4, 1H), 5.89 (s, 1H), 3.81-3.74 (m,4H), 3.49-3.41 (m, 4H).